Urinary excretion of relaxin after estradiol treatment of postmenopausal women

Clinical and Experimental Obstetrics and Gynecology

Volumn 23, Issue 2, 1996, Pages 65-69

  Lippert, T H ^a,c   Armbruster, F P ^b   Seeger, H ^a   Mueck, A O ^a   Zwirner, M ^a   Voelter, W ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Section of Clinical Pharmacology   (Germany)

Author keywords

Hormone replacement therapy; Postmenopausal women; Urinary relaxin excretion

Indexed keywords

ESTRADIOL; RELAXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RADIOIMMUNOASSAY; TRANSDERMAL DRUG ADMINISTRATION; URINARY EXCRETION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RELAXIN; TIME FACTORS; VASODILATION;

EID: 0029899807     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lippert T. H., Struck H., Voelter W. (eds.): "Relaxin - Das wiederentdeckte Hormon". Heidelberg, Germany, Springer Verlag, 1993.
2. Kakouris H., Eddie L. W., Summers R. J.: "Cardiac effects of relaxin in rats". Lancet, 1992, 339, 1076-1078.
3. Han X., Habuchu Y., Giles W. R.: "Relaxin increases heart rate by modulating calcium current in cardiac pacemaker cells". Circulation Res., 1993, 74, 537-541.
4. Ward D. G., Thomas G. R., Cronin M. J.: "Relaxin increases rat heart rate by a direct action on the cardiac atrium". Biochem. Biophys. Res. Commun, 1992, 186, 999-1005.
5. St. Louis J., Massiotte G.: "Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats". Life Sciences, 1985, 37, 1351-1357.
6. Bigazzi M., Del Mese A., Petrucci F., Casali R., Novelli G. P.: "The local administration of relaxin induces changes in the microcirculation of the rat mesocaecum". Acta Endocrinol., 1986, 112, 296-299.
7. Bani G., Bani Sacchi T., Bigazzi M., Bianchi S.: "Effects of relaxin on the microvasculature of mouse mammary gland". Histology and Histopathology, 1988, 3, 337-343.
8. Johnson M. R., Carter G., Grint C., Lightmann S. L.: "Relationship between ovarian steroids, gonadotrophins and relaxin during the menstrual cycle". Acta Endocrinol., 1993, 129, 121-125.
9. Gangar K. F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S.; "Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause". Lancet, 1991, 338, 839-842.
10. Muck A. O., Seeger H., Wiesner J., Korte K., Lippert T. H.: "Urinary prostanoids in postmenopausal women after transdermal and oral estrogen therapy". J. Obstet. Gynecol, 1994, 14, 341-345.
11. Mück A. O., Seeger H., Korte K., Haasis R., Lippert T. H.: "Is there any effect of estradiol on the vasodilating NO/cGMP-system? - investigations of the mechanism of cardiovascular protection by estrogen substitution in postmenopausal women", Zentralbl. Gynäkologie, 1994, 116, 507-511.
12. Bergmeyer H. U., Grassi M., Walter H.-E. In: Bergmeyer H. U. ed.: "Methods of enzymatic analysis". Vol. 2, Weinheim, Germany, VCH, 1983, 206-207.
13. Rabkin R., Ryan M. P., Duckworth W. C.: "The renal metabolism of insulin". Diabetologica, 1984, 27, 351-357.
14. Pickup J. C., Collins A. C. G., Keen H. "Urinary insulin excretion rate: an index of free insulinaemia in insulin-dependent diabetics". Diabetic Med., 1984, 1, 291-294.
15. Chetkowski R. J., Meldrum D. R., Steingold K. A., Randle D., Lu J., Eggena P. et al.: "Biologic effects of transdermal estradiol". N. Engl. J. Med., 1986, 4, 1615-1620.
16. Powers M. S., Schenkel L., Darley P. E., Good W. R , Balestra J. C., Place V. A.: "Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement". Am J. Obstet. Gynecol., 1985, 152, 1099-1106.